$349.88
1.92% yesterday
NYSE, Dec 26, 10:14 pm CET
ISIN
US0367521038
Symbol
ELV

Elevance Health Stock price

$343.30
+13.70 4.16% 1M
-33.12 8.80% 6M
-25.60 6.94% YTD
-29.64 7.95% 1Y
-170.99 33.25% 3Y
+34.63 11.22% 5Y
+202.74 144.24% 10Y
+265.00 338.44% 20Y
NYSE, Closing price Wed, Dec 24 2025
+0.08 0.02%

New AI Insights on Elevance Health Insights AI Insights on Elevance Health

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Key metrics

Basic
Market capitalization
$76.3b
Enterprise Value
$99.7b
Net debt
$23.4b
Cash
$8.7b
Shares outstanding
222.0m
Valuation (TTM | estimate)
P/E
13.9 | 11.3
P/S
0.4 | 0.4
EV/Sales
0.5 | 0.5
EV/FCF
26.8
P/B
1.7
Dividends
DPS
$6.84
Yield 1Y | 5Y
2.0% | 1.3%
Growth 1Y | 5Y
4.9% | 12.5%
Payout 1Y | 3Y
25.4% | 23.4%
Increased
15 Years
Financials (TTM | estimate)
Revenue
$194.8b | $200.2b
EBITDA
$9.1b | $10.6b
EBIT
$8.5b | $9.7b
Net Income
$5.5b | $6.7b
Free Cash Flow
$3.7b
Growth (TTM | estimate)
Revenue
12.0% | 13.2%
EBITDA
-9.8% | 8.6%
EBIT
-10.7% | 5.9%
Net Income
-13.8% | 12.5%
Free Cash Flow
337.3%
Margin (TTM | estimate)
Gross
-
EBITDA
4.7% | 5.3%
EBIT
4.4%
Net
2.8% | 3.4%
Free Cash Flow
1.9%
Financial Health
Equity Ratio
35.4%
Return on Equity
14.5%
ROCE
7.3%
ROIC
-
Debt/Equity
0.7
More
EPS
$24.7
FCF per Share
$16.8
Short interest
2.2%
Employees
104k
Rev per Employee
$1.7m
Show more

Is Elevance Health a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,079 stocks worldwide.

Elevance Health Stock Analysis

Unlock Scores for Free

Analyst Opinions

28 Analysts have issued a Elevance Health forecast:

16x Buy
57%
12x Hold
43%

Analyst Opinions

28 Analysts have issued a Elevance Health forecast:

Buy
57%
Hold
43%

Financial data from Elevance Health

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
194,820 194,820
12% 12%
100%
- Policy Benefits 143,658 143,658
15% 15%
74%
51,162 51,162
5% 5%
26%
- SG&A - -
-
-
- Other operating expenses 42,041 42,041
9% 9%
22%
9,121 9,121
10% 10%
5%
- Depreciation and Amortization 644 644
4% 4%
0%
8,477 8,477
11% 11%
4%
- Interest Expense 1,376 1,376
25% 25%
1%
- Tax Expense 1,573 1,573
18% 18%
1%
Net Profit 5,533 5,533
14% 14%
3%

In millions USD.

Don't miss a Thing! We will send you all news about Elevance Health directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Elevance Health Stock News

Neutral
Business Wire
4 days ago
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) will release fourth quarter and full year 2025 financial results on January 28, 2026, at 6:00 a.m. Eastern Standard Time (“EST”). Management will review these results and its outlook during a conference call at 8:30 a.m. EST that same morning. The conference call should be accessed at least 15 minutes prior to its start with the followi...
Neutral
Business Wire
14 days ago
INDIANAPOLIS--(BUSINESS WIRE)--As 2025 draws to a close, Elevance Health highlights how today's health plans are evolving to better support their members in a broader range of situations that affect health, including cancer diagnoses, mental health crises, and unexpected health concerns during pregnancy. From employer-sponsored health insurance to government-sponsored programs, health plans are...
Neutral
Business Wire
14 days ago
OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICRs) of “a+” (Excellent) of the core Blue Cross Blue Shield (BCBS)-branded insurance subsidiaries of Elevance Health, Inc. (Elevance) (Indianapolis, IN) [NYSE: ELV], as well as most of its non-Blue-branded subsidiaries. In add...
More Elevance Health News

Company Profile

Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Commercial and Specialty Business, Government Business, CarelonRx, and Other. The Commercial and Specialty Business segment provides insurance products and services such as stop loss, dental, vision, life, disability and supplemental health insurance. The Government Business segment includes medicare and medicaid businesses, national government services, and services provided to the federal government. The CerelonRx segment offers formulary management, pharmacy networks, prescription drug database, member services, and mail order capabilities. The Other segment is involved in health services business focused on quality of healthcare by enabling and creating new care delivery and payment models. The company was founded in 1944 and is headquartered in Indianapolis, IN.

Head office United States
CEO Gail Boudreaux
Employees 104,200
Founded 1944
Website www.elevancehealth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today